Literature DB >> 2302928

Expanded gentamicin volume of distribution in patients with indicators of malnutrition.

B J Zarowitz1, A M Pilla, J Popovich.   

Abstract

Visceral protein, body weight, and body composition were assessed in patients receiving gentamicin to determine whether a meaningful analysis of nutritional status can be used to identify patients with an expanded gentamicin volume of distribution (V). Adults with gram-negative infections were selected sequentially from among hospitalized patients being treated with gentamicin. Serum gentamicin concentrations before and after an intravenous dose of gentamicin were determined by an enzyme-mediated immunoassay. Noncompartmental analysis was used to determine pharmacokinetic variables. Body composition was assessed by bioelectric impedance techniques. Of 26 patients, 10 were considered to be at high risk of malnutrition by meeting at least two of the following criteria: serum albumin concentration, less than or equal to 3.5 g/dL; actual weight, less than 80% of ideal weight; and ratio of exchangeable sodium to exchangeable potassium (Nae/Ke), greater than 1.22. The non-high-risk group (n = 16) had a gentamicin V at steady state of 0.294 +/- 0.105 L/kg (mean +/- S.D.), which was significantly lower than that observed in the high-risk group (0.415 +/- 0.294 L/kg). The accuracy of the high risk classification in identifying patients with an expanded gentamicin V was improved by revising the definition of the high-risk group. In the revised definition, patients were considered to be at high risk for malnutrition if they met at least two of the following criteria: serum albumin concentration, less than or equal to 3.1 g/dL; actual weight, less than 90% of ideal weight; and Nae/Ke' greater than 1.22.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2302928

Source DB:  PubMed          Journal:  Clin Pharm        ISSN: 0278-2677


  5 in total

Review 1.  Pharmacokinetics of drugs in cystic fibrosis.

Authors:  M Spino
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

2.  Population pharmacokinetics of gentamicin. Use of the nonparametric expectation maximisation (NPEM) algorithm.

Authors:  D F Kisor; S M Watling; B J Zarowitz; R W Jelliffe
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

3.  Variation in the pharmacokinetics of gentamicin and tobramycin in patients with pleural effusions and hypoalbuminemia.

Authors:  J V Etzel; A N Nafziger; J S Bertino
Journal:  Antimicrob Agents Chemother       Date:  1992-03       Impact factor: 5.191

4.  Effects of fasting on temporal variations in nephrotoxicity of gentamicin in rats.

Authors:  D Beauchamp; P Collin; L Grenier; M LeBrun; M Couture; L Thibault; G Labrecque; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

Review 5.  Selected pharmacokinetic issues of the use of antiepileptic drugs and parenteral nutrition in critically ill patients.

Authors:  Muhannad R M Salih; Mohd Baidi Bahari; Arwa Y Abd
Journal:  Nutr J       Date:  2010-12-31       Impact factor: 3.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.